Although this competitive phenomenon has not yet been observed in the brain, it may be a significant reason for the poor efficacy and side effects of many therapeutic approaches, warranting further investigation
17 Similarly, a group from Taiwan analyzed data from the Taiwan National Health Insurance Research Database and ultimately didnt find an increased risk of vision-threatening retinopathy with GLP-1 RA use and a possible decreased risk compared to DPP-4i
Individual results vary based on starting weight, metabolic health, consistency with nutrition guidance, and activity level
IV therapy can combat inflammation by administering substances like glutathione, a powerful antioxidant that reduces oxidative stress
Jensterle M, Kravos NA, Pfeifer M, Kocjan T, Janez A